Efficacy of a Low-Dose Omeprazole-Based Triple-Therapy Regimen for Helicobacter pylori Eradication Independent of Cytochrome P450 Genotype: The Japanese MACH Study

Author： Kuwayama Hajime  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.5, 2005-01, pp. : 293-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-dose clarithromycin has efficacy similar to high-dose clarithromycin in omeprazole-based triple therapy for Helicobacter pylori eradication

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Low-dose omeprazole-based triple therapy eradicates H. pylori

By  

Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Helicobacter pylori Eradication Therapy with Omeprazole, Amoxicillin and High- and Low-Dose Clarithromycin in Japanese Patients: A Randomised, Double-Blind, Multicentre Study

By Higuchi Kazuhide  

Clinical Drug Investigation, Vol. 26, Iss. 7, 2006-01 ,pp. : 403-414

Adis International

Access to resources Recommend Favorite

Toxic Epidermal Necrolysis Induced by a Triple-Drug Regimen for Helicobacter Pylori Eradication

By Matsukawa Y.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 301-303

Adis International

Access to resources Recommend Favorite

Cytochrome P450 2C19 (CYP2C19) genotype appears to affect the efficacy of omeprazole

By  

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite